Emily Tharp is a Houston, Texas based neurologist who is specialized in Neurology. Active license number of Emily Tharp is U3667 for Neurology in Texas. Her current practice location is 6410 Fannin, Suite 1014, Houston. Patients can reach her at 832-325-7080. Emily Tharp is MD in Neurology and her NPI number (Unique professional ID assigned by NPPES) is 1063970341. Emily Tharp specializes in the diagnosis and treatment of diseases or impaired function of the brain, spinal cord, peripheral nerves, muscles, autonomic nervous system, and blood vessels that relate to these structures.
Complete Profile:
Emily Tharp speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
Name:
Emily Tharp
Specialization:
Neurology
Gender:
Female
Credentials:
MD
Practice Address:
6410 Fannin, Suite 1014, Houston, Texas, 77030
Phone:
832-325-7080
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1063970341
NPI Enumeration Date:
06 Mar, 2019
NPI Last Update On:
15 May, 2025
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Emily Tharp are as mentioned below.
License Number
Specialization
State
Status
U3667
Neurology
Texas
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Emily Tharp 6431 Fannin, Msb 7.044 Houston, Texas
Zip:
77030
Patients can reach Emily Tharp at 6410 Fannin, Suite 1014, Houston, Texas or can call to book an appointment on 832-325-7080.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 June, 2025.